This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q68717143
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel im Mai 1966 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 May 1966 наукова стаття, опублікована в травні 1966 artículu científicu espublizáu en mayu de 1966
p:P577
wds:Q68717143-32E45A3A-7975-458C-8A6F-CE8A8368695A
wdt:P577
1966-05-01T00:00:00Z
p:P2093
wds:Q68717143-37A970EB-D130-48AE-B57A-CC543DC793BB wds:Q68717143-48908721-06FF-449A-8864-88D536F18882 wds:Q68717143-C770CC1B-5156-4F42-B785-26EDEDED824F
wdt:P2093
R Cheli G Bertaccini G De Caro
rdfs:label
Enlargement of salivary glands in rats after chronic administration of physalaemin or isoprenaline Enlargement of salivary glands in rats after chronic administration of physalaemin or isoprenaline
skos:prefLabel
Enlargement of salivary glands in rats after chronic administration of physalaemin or isoprenaline Enlargement of salivary glands in rats after chronic administration of physalaemin or isoprenaline
schema:name
Enlargement of salivary glands in rats after chronic administration of physalaemin or isoprenaline Enlargement of salivary glands in rats after chronic administration of physalaemin or isoprenaline
p:P1476
wds:Q68717143-ACF08951-81E5-4E72-A26A-56CE7111DCA0
wdt:P1476
Enlargement of salivary glands in rats after chronic administration of physalaemin or isoprenaline
p:P304
wds:Q68717143-25084AF8-9A5C-48A4-98F1-192D1F089E83
wdt:P304
312-316
p:P31
wds:Q68717143-47BF2BCF-6709-411D-A58D-C759E7FFBB1A
wdt:P31
wd:Q13442814
p:P698
wds:Q68717143-EE418337-B296-4A29-87D6-C14023D41E60
wdtn:P698
n12:4380000
wdt:P698
4380000
p:P1433
wds:Q68717143-6912C78A-230A-4A15-A4AC-746A93A7CB69
wdt:P1433
wd:Q10532762
p:P433
wds:Q68717143-C61F5FAC-DCD3-4438-BDAB-4298323AC21F
p:P478
wds:Q68717143-842CF942-62F6-4D18-8B87-43C7DDC91F9E
wdt:P433
5
wdt:P478
18
p:P356
wds:Q68717143-3A283771-CC52-4003-B37E-063C6A3A8B3F
wdtn:P356
n8:J.2042-7158.1966.TB07877.X
wdt:P356
10.1111/J.2042-7158.1966.TB07877.X